Omer N. Pamuk, MD, graduated from Istanbul University, Istanbul School of Medicine, in Turkey. He completed his internal medicine residency training at Istanbul University, Cerrahpasa School of Medicine, and his rheumatology fellowship training at Trakya University.
Dr. Pamuk gained laboratory research experience at Harvard Medical School, Beth Israel Deaconess Medical Center, Division of Rheumatology. Under the mentorship of Dr. George Tsokos, he explored the pathogenesis of multiple immune cell abnormalities in systemic lupus erythematosus. He took summer courses at the Harvard School of Public Health, including principles in clinical trials and measuring health outcomes.
Dr. Pamuk worked at an academic medical center in northwestern Turkey as a rheumatologist from 2005-2016. He completed a second rheumatology fellowship training at the National Institutes of Health.
Dr. Pamuk has extensive experience in both clinical and laboratory research. He has authored many multicenter studies and published articles in journals such as Arthritis Care Research, Arthritis Research & Therapy, the Journal of Rheumatology, Clinical Rheumatology, Lupus and others. Dr. Pamuk’s research is focused on systemic lupus erythematosus.
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood, OH 44122
Strongsville Medical Center
18181 Pearl Rd
Strongsville, OH 44136
Patient Experience Reviews
4.1 out of 5
Patient Comments (4)
Reviewed On 9/1/2023
This doctor was the best experience I've had along with my surgery experience. I would like to stay with him.
Reviewed On 9/1/2023
Overall, everything was outstanding.
Reviewed On 8/1/2023
Reviewed On 6/1/2023
This was my initial visit with provider. HeWas kind, professional, and informative.I liked him and highly recommend him.
Fellowship | Rheumatology
Rheumatology - National Institutes Of Health (2019 - 2022)
Istanbul University School Of Medicine (1995)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Omer Pamuk did not disclose any Outside Relationships with Industry.